Therefore, we aim to evaluate the effects of globular adiponectin in treatment of type 2 diabetic combined with NAFLD rats induced by high-fat/STZ and further explore the interaction between gAd and adipoR1/R2 in liver and skeletal muscle. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.